Practice question

Answer the question and get instant feedback.

ModerateEndocrinologyCombination cardiometabolic therapyus-abimus-usmle-step-2

A 53-year-old with T2DM (A1c 7.4%) and CKD asks about GLP‑1 RA vs SGLT2. He already takes an SGLT2 inhibitor. Next best agent for ASCVD risk reduction?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.